IMS Capital Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-6,145
Closed -$490K 144
2024
Q1
$490K Hold
6,145
0.23% 87
2023
Q4
$485K Sell
6,145
-3,610
-37% -$257K 0.24% 88
2023
Q3
$681K Buy
9,755
+194
+2% +$13.7K 0.41% 63
2023
Q2
$661K Buy
9,561
+258
+3% +$18.4K 0.37% 66
2023
Q1
$691K Buy
9,303
+150
+2% +$12.6K 0.41% 67
2022
Q4
$853K Buy
9,153
+725
+9% +$70K 0.54% 58
2022
Q3
$804K Buy
8,428
+1,210
+17% +$120K 0.56% 53
2022
Q2
$669K Buy
7,218
+380
+6% +$37.1K 0.43% 67
2022
Q1
$692K Buy
6,838
+1,310
+24% +$138K 0.36% 73
2021
Q4
$570K Buy
5,528
+2,566
+87% +$237K 0.29% 72
2021
Q3
$251K Buy
2,962
+193
+7% +$16.2K 0.15% 119
2021
Q2
$231K Hold
2,769
0.14% 118
2021
Q1
$208K Sell
2,769
-11,559
-81% -$842K 0.13% 117
2020
Q4
$979K Buy
14,328
+5,050
+54% +$328K 0.61% 44
2020
Q3
$542K Buy
9,278
+850
+10% +$52.9K 0.39% 65
2020
Q2
$548K Hold
8,428
0.42% 67
2020
Q1
$500K Buy
+8,428
New +$563K 0.51% 64
2018
Q4
Sell
-1,058
Closed -$83K 177
2018
Q3
$83K Hold
1,058
0.06% 161
2018
Q2
$68K Buy
+1,058
New +$69.7K 0.04% 160

Other funds holding CVS

IMS Capital Management's CVS Position: Q2 2024 in Review

IMS Capital Management sold out of CVS Health (CVS) in Q2 2024, closing a stake of 6,145 shares — an estimated $490K sold.

IMS Capital Management first reported a position in CVS in Q2 2018 and held it in 19 quarters. The position peaked at $979K in Q4 2020. 1,911 funds tracked by Wall St. Rank hold CVS as of Q2 2024.

  • IMS Capital Management reported no remaining CVS Health position as of Q2 2024 after selling out during the quarter.
  • IMS Capital Management sold 6,145 CVS Health shares in Q2 2024, an estimated $490K.
  • IMS Capital Management first reported a position in CVS Health in Q2 2018 and held it in 19 quarters.
  • IMS Capital Management's CVS Health position peaked at $979K in Q4 2020.
  • 1,911 funds tracked by Wall St. Rank held CVS Health as of Q2 2024.

Based on IMS Capital Management's 13F filing for Q2 2024, filed 21 Aug 2024.